Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the alpha 2/3/5-Subtype Selective GABA(A)-Positive Allosteric Modulator PF-06372865 in Healthy Volunteers

Gurrell, R; Whitlock, M; Wei, H; Shen, ZZ; Ogden, A

Gurrell, R (corresponding author), Cerevel Therapeut LLC, Boston, MA 02116 USA.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, ; ():